Literature DB >> 8310207

Abnormal T-cell function in patients with psoriatic arthritis: evidence for decreased interleukin 2 production.

J G Fort1, J B Smith, J L Abruzzo.   

Abstract

Psoriatic arthritis (PSA) is an inflammatory arthritis associated with psoriasis. Although not considered an autoimmune process, there is evidence for humoral and cellular immune abnormalities similar to autoimmune diseases such as rheumatoid arthritis and systemic lupus (SLE). We investigated mitogen-induced proliferation and interleukin 2 (IL-2) production by peripheral blood mononuclear cells in patients with PSA. Both IL-2 production and proliferation were significantly decreased in PSA patients when compared to controls. Increased arachidonic acid metabolism has been reported in skin and peripheral mononuclear cells of patients with psoriasis and PSA. We therefore also investigated the effect of indomethacin and prostaglandin E2 (PGE2) on IL-2 production. Addition of indomethacin to cultures did not significantly change IL-2 production in patients with PSA, but did so in controls. PGE2 produced a significant reduction in IL-2 production in PSA and in controls.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8310207     DOI: 10.1007/BF00301262

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

1.  Subpopulations of T lymphocytes in psoriasis patients and their changes during immunotherapy.

Authors:  A Y Rubins; A G Merson
Journal:  J Am Acad Dermatol       Date:  1987-12       Impact factor: 11.527

Review 2.  Psoriatic arthritis.

Authors:  J M Moll; V Wright
Journal:  Semin Arthritis Rheum       Date:  1973       Impact factor: 5.532

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.

Authors:  S Chouaib; K Welte; R Mertelsmann; B Dupont
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

5.  Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  N Miyasaka; T Nakamura; I J Russell; N Talal
Journal:  Clin Immunol Immunopathol       Date:  1984-04

6.  Circulating immune complexes, serum immunoglobulins, and acute phase proteins in psoriasis and psoriatic arthritis.

Authors:  M R Laurent; G S Panayi; P Shepherd
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

7.  Aberrations in T-cell subpopulations in patients with psoriasis and psoriatic arthritis.

Authors:  D D Gladman; E C Keystone; R K Schacter
Journal:  J Invest Dermatol       Date:  1983-04       Impact factor: 8.551

8.  Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.

Authors:  C Walker; F Kristensen; F Bettens; A L deWeck
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

9.  Functional consequences of perceived interleukin deficiencies? Analysis employing NZB x C58 recombinant inbred mice.

Authors:  M H Bocchieri; J B Smith; J B Smith; M J Staruch; D D Wood
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

10.  Immunological abnormalities in psoriatic arthropathy.

Authors:  J Sany; J Clot
Journal:  J Rheumatol       Date:  1980 Jul-Aug       Impact factor: 4.666

View more
  1 in total

Review 1.  Complexities in Genetics of Psoriatic Arthritis.

Authors:  Sara Rahmati; Lam Tsoi; Darren O'Rielly; Vinod Chandran; Proton Rahman
Journal:  Curr Rheumatol Rep       Date:  2020-03-12       Impact factor: 4.592

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.